Regulation of oxidative stress by pituitary adenylate cyclase-activating polypeptide (PACAP) mediated by PACAP receptor

Journal of Molecular Neuroscience

Volumn 42, Issue 3, 2010, Pages 397-403

  Ohtaki, Hirokazu ^a   Satoh, Atsushi ^a   Nakamachi, Tomoya ^a   Yofu, Sachiko ^a,b   Dohi, Kenji ^a   Mori, Hiroyoshi ^a   Ohara, Kenji ^a   Miyamoto, Kazuyuki ^a   Hashimoto, Hitoshi ^c   Shintani, Norihito ^c   Baba, Akemichi ^c   Matsunaga, Masaji ^b   Shioda, Seiji ^a  

^a SHOWA UNIVERSITY   (Japan)

^b Gene Trophology Research Institute   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Aging; Oxidative stress; PACAP; PACAP specific receptor (PAC1R)

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE[6-38]; POLYPEPTIDE; RADICAL; SCAVENGER; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MALE; METABOLITE; MOUSE; NONHUMAN; OXIDATIVE STRESS; RECEPTOR INTRINSIC ACTIVITY; WILD TYPE;

AGE FACTORS; ANIMALS; ANTIOXIDANTS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; REACTIVE OXYGEN SPECIES; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE;

ANIMALIA; MUS;

EID: 78349307902     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-010-9350-0     Document Type: Article

References (39)

1. C Abad C Martinez J Leceta MG Juarranz M Delgado RP Gomariz 2002 Pituitary adenylate-cyclase-activating polypeptide expression in the immune system Neuroimmunomodulation 10 177 186 1:CAS:528:DC%2BD38XpsV2htbc%3D 10.1159/000067180 12481158
2. A Arimura 1998 Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems Jpn J Physiol 48 301 331 1:CAS:528:DyaK1MXlvFSq 10.2170/jjphysiol.48.301 9852340
3. A Arimura M Li V Batuman 2005 Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury Blood 107 661 668 10.1182/blood-2005-03-1186 16204306
4. R Borzsei L Mark A Tamas, et al. 2009 Presence of pituitary adenylate cyclase activating polypeptide-38 in human plasma and milk Eur J Endocrinol 160 561 565 1:CAS:528:DC%2BD1MXpsFOktb4%3D 10.1530/EJE-08-0911 19174531
5. B Botia D Seyer A Ravni, et al. 2008 Peroxiredoxin 2 is involved in the neuroprotective effects of PACAP in cultured cerebellar granule neurons J Mol Neurosci 36 61 72 1:CAS:528:DC%2BD1cXhsVagtLrL 10.1007/s12031-008-9075-5 18491044
6. Y Chiba A Shimada N Kumagai, et al. 2009 The senescence-accelerated mouse (SAM): a higher oxidative stress and age-dependent degenerative diseases model Neurochem Res 34 679 687 1:CAS:528:DC%2BD1cXhtlKisLrI 10.1007/s11064-008-9812-8 18688709
7. M Delgado D Ganea 2001 Inhibition of endotoxin-induced macrophage chemokine production by VIP and PACAP in vitro and in vivo Arch Physiol Biochem 109 377 382 1:CAS:528:DC%2BD38Xmt12htr0%3D 11935377
8. M Fujimura Y Morita-Fujimura M Kawase, et al. 1999 Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome c and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice J Neurosci 19 3414 3422 1:CAS:528:DyaK1MXislGrs7w%3D 10212301
9. D Ganea M Delgado 2002 Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity Crit Rev Oral Biol Med 13 229 237 10.1177/ 154411130201300303 12090463
10. B Gasz B Racz E Roth, et al. 2006 Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis Peptides 27 87 94 1:CAS:528:DC%2BD28Xktl2nug%3D%3D 10.1016/j.peptides.2005.06. 022 16095757
11. DA Groneberg KF Rabe A Fischer 2006 Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors Eur J Pharmacol 533 182 194 1:CAS:528:DC%2BD28XitVKgsr8%3D 10.1016/j.ejphar.2005.12. 055 16473346
12. H Hashimoto N Shintani K Tanaka, et al. 2001 Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP) Proc Natl Acad Sci U S A 98 13355 13360 1:CAS:528:DC%2BD3MXosFygtb8%3D 10.1073/pnas.231094498 11687615
13. H Hashimoto N Shintani A Baba 2006 New insights into the central PACAPergic system from the phenotypes in PACAP- and PACAP receptor-knockout mice Ann N Y Acad Sci 1070 75 89 1:CAS:528:DC%2BD28XpvVehsLk%3D 10.1196/annals.1317. 038 16888150
14. G Horvath L Mark R Brubel, et al. 2010 Mice deficient in pituitary adenylate cyclase activating polypeptide display increased sensitivity to renal oxidative stress in vitro Neurosci Lett 469 1 70 74 1:CAS:528:DC%2BC3cXotFCq 10.1016/j.neulet.2009.11.046 19932736
15. M Kawase K Murakami M Fujimura, et al. 1999 Exacerbation of delayed cell injury after transient global ischemia in mutant mice with CuZn superoxide dismutase deficiency Stroke 30 1962 1968 1:CAS:528:DyaK1MXmtFKlsr8%3D 10471451
16. J Kinhult R Uddman LO Cardell 2001 The induction of carbon monoxide-mediated airway relaxation by PACAP 38 in isolated guinea pig airways Lung 179 1 8 1:CAS:528:DC%2BD3MXmsVOmsLc%3D 10.1007/s004080000043 11479689
17. M Li S Balamuthusamy AM Khan JL Maderdrut EE Simon V Batuman 2010 Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury Peptides 31 4 592 602 1:CAS:528:DC%2BC3cXjt1Glsbg%3D 10.1016/j.peptides.2009.12.018 20034524
18. L Linden 1999 PACAPs-potential for bronchodilation Pulm Pharmacol Ther 12 229 236 1:CAS:528:DyaK1MXmt1ajtLk%3D 10.1006/pupt.1999.0209 10500002
19. C Martinez C Abad M Delgado, et al. 2002 Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor Proc Natl Acad Sci U S A 99 1053 1058 1:CAS:528:DC%2BD38Xht1Wit70%3D 10.1073/pnas. 012367999 11792830
20. A Miyata A Arimura RR Dahl, et al. 1989 Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells Biochem Biophys Res Commun 164 567 574 1:CAS:528:DyaK3cXps1Y%3D 10.1016/0006-291X(89)91757-9 2803320
21. H Mizushima CJ Zhou K Dohi, et al. 2002 Reduced postischemic apoptosis in the hippocampus of mice deficient in interleukin-1 J Comp Neurol 448 203 216 1:CAS:528:DC%2BD38XkvV2kur4%3D 10.1002/cne.10262 12012430
22. Mori H, Nakamachi T, Ohtaki H et al (2010) Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on doxorubicin-induced cardiomyopathy in mice. Circ J (in press)
23. H Ohtaki H Funahashi K Dohi, et al. 2003 Suppression of oxidative neuronal damage after transient middle cerebral artery occlusion in mice lacking interleukin-1 Neurosci Res 45 313 324 1:CAS:528:DC%2BD3sXhvFKju7s%3D 10.1016/S0168-0102(02)00238-9 12631467
24. H Ohtaki K Dohi S Yofu, et al. 2004 Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content-treatment in central nervous system of mice Regul Pept 123 61 67 1:CAS:528: DC%2BD2cXptFOlt7k%3D 10.1016/j.regpep.2004.05.013 15518894
25. H Ohtaki T Nakamachi K Dohi, et al. 2006 Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6 Proc Natl Acad Sci U S A 103 7488 7493 1:CAS:528:DC%2BD28XkslOrtb8%3D 10.1073/pnas.0600375103 16651528
26. H Ohtaki T Takeda K Dohi, et al. 2007 Increased mitochondrial DNA oxidative damage after transient middle cerebral artery occlusion in mice Neurosci Res 58 349 355 1:CAS:528:DC%2BD2sXovFKmt74%3D 10.1016/j.neures.2007.04. 005 17628732
27. H Ohtaki T Nakamachi K Dohi S Shioda 2008 Role of PACAP in ischemic neural death J Mol Neurosci 36 16 25 1:CAS:528:DC%2BD1cXhsVagtLvJ 10.1007/s12031-008-9077-3 18483879
28. H Ohtaki S Yofu T Nakamachi, et al. 2010 Nucleoprotein diet ameliorates arthritis symptoms in mice transgenic for human T-cell leukemia virus type I (HTLV-1) J Clin Biochem Nutr 46 1 12 10.3164/jcbn.09-61
29. B Racz B Gasz B Borsiczky, et al. 2007 Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis Gen Comp Endocrinol 153 115 123 1:CAS:528: DC%2BD2sXotlSit7g%3D 10.1016/j.ygcen.2006.12.006 17270184
30. B Racz G Horvath D Reglodi, et al. 2010 PACAP ameliorates oxidative stress in the chicken inner ear: An in vitro study Regul Pept 160 1-3 91 98 1:CAS:528:DC%2BC3cXhtlWktbk%3D 10.1016/j.regpep.2009.12.003 19969027
31. YS Rajawat Z Hilioti I Bossis 2009 Aging: central role for autophagy and the lysosomal degradative system Ageing Res Rev 8 199 213 1:CAS:528: DC%2BD1MXptVKrtLo%3D 10.1016/j.arr.2009.05.001 19427410
32. A Ravni S Bourgault A Lebon, et al. 2006 The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways J Neurochem 98 321 329 1:CAS:528:DC%2BD28Xot1Omsrk%3D 10.1111/j.1471-4159.2006.03884.x 16805827
33. D Reglodi A Somogyvari-Vigh S Vigh T Kozicz A Arimura 2000 Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat Stroke 31 1411 1417 1:CAS:528: DC%2BD3cXkt1Cnt74%3D 10835464
34. D Reglodi Z Fabian A Tamas, et al. 2004 Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals Regul Pept 123 51 59 1:CAS:528:DC%2BD2cXptFOlt7g%3D 10.1016/j.regpep.2004.05.012 15518893
35. D Uchida A Arimura A Somogyvari-Vigh S Shioda WA Banks 1996 Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide Brain Res 736 280 286 1:CAS:528:DyaK28XmtV2js78%3D 10.1016/0006-8993(96)00716-0 8930334
36. D Vaudry BJ Gonzalez M Basille L Yon A Fournier H Vaudry 2000 Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions Pharmacol Rev 52 269 324 1:CAS:528:DC%2BD3cXks1SksL0%3D 10835102
37. D Vaudry TF Pamantung M Basille, et al. 2002 PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis Eur J NeuroSci 15 1451 1460 1:STN:280:DC%2BD38zitlOltA%3D%3D 10.1046/j.1460-9568.2002.01981.x 12028355
38. D Vaudry C Hamelink R Damadzic RL Eskay B Gonzalez LE Eiden 2005 Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insult Peptides 26 2518 2524 1:CAS:528: DC%2BD2MXht1Ggtr3F 10.1016/j.peptides.2005.05.015 16009465
39. P Voss W Siems 2006 Clinical oxidation parameters of aging Free Radic Res 40 1339 1349 1:CAS:528:DC%2BD28XhtlGqs7nE 10.1080/10715760600953859 17090423